| トルコ | オーストリア | スペイン | |
| 陽子線治療 | から $70,000 | から $80,000 | から $25,393 |
| 腹腔鏡下前立腺摘除術 | から $7,500 | から $18,000 | から $14,000 |
| 経尿道的前立腺切除術 | から $3,580 | から $5,500 | から $4,000 |
| 小線源治療 | から $3,465 | から $15,000 | から $10,000 |
| 前立腺癌の密封小線源治療 | から $2,500 | から $9,000 | から $8,000 |
Galceran教授はバル・デブロン病院でスペインの泌尿生殖器がんユニットを率い、900件以上の手術実績と全国臨床試験を有する前立腺がんの専門家です。
Dr. Antonio Alcaraz is a Spanish uro-oncologist and transplantologist with over 30 years of experience and 500 successful operations, specializing in the treatment of prostate cancer, kidney, bladder, and other urogenital system pathologies using minimally invasive and robotic systems, as well as congenital pathologies in children. He is a member of several prestigious urological societies.
Dr. Enrique Grande, MD, PhD, MSc, is a medical oncologist with more than 20 years of experience. He is an international expert in genitourinary and neuroendocrine tumors. He directs the Medical Oncology Department and the One Oncology Madrid Cancer Program at QuirónSalud, Spain’s largest private healthcare network. He leads an integrated, multidisciplinary model with access to targeted therapies and clinical trials.
He is a pioneer in precision oncology. He uses molecular profiling and biomarker-based care. He has authored more than 300 peer-reviewed papers. He serves as a principal investigator and sits on steering committees for many international trials. These studies help set standards of care in urothelial bladder and neuroendocrine tumors. He contributes to guidelines and programs at ESMO, ASCO, ENETS, and EAU.